IDO affects T cell proliferation and promotes immunosuppression — e.g., by impairing TB control pathways like phagolysosome fusion and autophagy (15, 16) — inhibiting CD4+ T cell proliferation in the absence of Trp and expanding Tregs and MDSCs. Here, CD4 is linked to tuberculosis.